Active, Not Recruiting
The Phase-2 CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen Trial (CLOVER)
NCT06699836
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
- Locations
-
- City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
- Pacific Hematology Oncology Associates San Francisco, California, United States
- Georgetown University Medical Center Washington D.C., District of Columbia, United States
- Norton Cancer Institute, Brownsboro Hospital Campus Louisville, Kentucky, United States